Dr Orfali is a medical graduate of NUI Galway. After completing her internal medicine training between Galway University Hospital and the Mayo Clinic in Minnesota, she branched into laboratory research, spending three years in laboratories at the Cork Cancer Research Centre and Weill Cornell University in New York. Dr Orfali was awarded a PhD from UCC for her work on the role of autophagy in leukaemic cell differentiation.

Dr Orfali trained as a haematology specialist here in Ireland and then returned to Cornell University in New York to undertake further specialist training in stem cell transplantation for two years. She returned to Dublin in 2020 to take up her position on the Adult Bone Marrow Transplant team.

MB BCh BAO MRCPI FRCPath PhD

• Royal College of Physicians of Ireland
• Royal College of Pathology, UK
• Haematology Association of Ireland (HAI)
• American Society of Haematology (ASH)
• American Society of Transplantation and Cellular Therapy (ASTCT)

Malignant myeloid disease including; acute myeloid leukaemia, myelodysplastic syndromes and myeloproliferative disorders. Stem cell transplantation and long-term survivorship post-transplant.

Dr Orfali’s research focuses on finding strategies to reduce relapse and strengthen the immune system after donor stem cell transplantation. She is also interested in the significance and prognostic impact of gene mutations in myeloid disease. She has published in these areas and maintains working collaborations with researchers at Cornell University in New York.